1 – 10 of 104
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
A Story of Combining Immunotherapy with Ultra-Hypo-Fractionated Radiation Therapy.
(
- Contribution to journal › Scientific review
-
Mark
Spatial distribution of tertiary lymphoid structures in the molecular and clinical context of non-small cell lung cancer
(
- Contribution to journal › Article
- 2024
-
Mark
Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology : a post hoc analysis of the “ADAMANT” randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial
(
- Contribution to journal › Article
-
Mark
Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer’s disease, positive for plasma p-tau217
(
- Contribution to journal › Article
-
Mark
Defining neuroblastoma : From origin to precision medicine
(
- Contribution to journal › Scientific review
-
Mark
Revival of recombinant IL-2 therapy–approaches from the past until today
(
- Contribution to journal › Scientific review
-
Mark
Biomarkers in mesothelioma and non-small cell lung cancer - Investigation of cytological specimens with correlation to histology
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Therapeutic Effects of IL-1RA against Acute Bacterial Infections, including Antibiotic-Resistant Strains
(
- Contribution to journal › Article
-
Mark
Empowering macrophages : the cancer fighters within the tumour microenvironment in mantle cell lymphoma
(
- Contribution to journal › Article
-
Mark
Fine tuning of the innate and adaptive immune responses by Interleukin-2
(
- Contribution to journal › Article